Verve Therapeutics Company Insiders

Verve Therapeutics Management Team Effectiveness

The company has return on total asset (ROA) of (0.2219) % which means that it has lost $0.2219 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4067) %, meaning that it created substantial loss on money invested by shareholders. Verve Therapeutics' management efficiency ratios could be used to measure how well Verve Therapeutics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.28 in 2024. Return On Capital Employed is likely to drop to -0.33 in 2024. At this time, Verve Therapeutics' Net Tangible Assets are fairly stable compared to the past year. Non Current Assets Total is likely to climb to about 120.5 M in 2024, whereas Other Assets are likely to drop slightly above 3.9 M in 2024. Common Stock Shares Outstanding is likely to drop to about 57.9 M in 2024. Net Loss is likely to climb to about (134.6 M) in 2024

Verve Therapeutics Workforce Comparison

Verve Therapeutics Insider Trading History

Verve Therapeutics Notable Stakeholders

The success or failure of an entity such as Verve Therapeutics often depends on how effective the management is. Verve Therapeutics management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Verve management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Verve management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the imprecision that can be found in Verve Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Verve Therapeutics. Check Verve Therapeutics' Beneish M Score to see the likelihood of Verve Therapeutics' management manipulating its earnings.

When running Verve Therapeutics' price analysis, check to measure Verve Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Verve Therapeutics is operating at the current time. Most of Verve Therapeutics' value examination focuses on studying past and present price action to predict the probability of Verve Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Verve Therapeutics' price. Additionally, you may evaluate how the addition of Verve Therapeutics to your portfolios can decrease your overall portfolio volatility.